Literature DB >> 1712540

Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases.

N G Ordóñez1, A K El-Naggar, R C Hickey, N A Samaan.   

Abstract

To study the histogenesis of and determine the most useful markers for diagnosing anaplastic thyroid carcinoma (ATC), 32 cases, including 2 with numerous osteoclast-like cells, were stained with a battery of antibodies to epithelial (keratin, epithelial membrane antigen [EMA], carcinoembryonic antigen [CEA]), mesenchymal (vimentin, desmin, muscle-specific actin [MSA], Factor VIII-related antigen [FVIII:RAg]), endocrine (thyroglobulin, calcitonin, chromogranin [Cg]), lymphocytic (leukocyte common antigen [LCA]), histiocytic (alpha-1-antitrypsin [alpha 1AT], alpha-1-antichymotrypsin [alpha 1AChy], KP1), melanocytic (HMB-45), and Schwann cell (S-100 protein) markers. Five tumors were associated with papillary carcinoma. In one of these cases, a morphologic continuum between the well-differentiated carcinoma and the ATC was visualized by their positive immunostaining for both vimentin and keratin, thus supporting the hypothesis that the latter tumor originated from the former. Twenty-five (78.1%) tumors expressed keratin, 10 (31.3%) reacted for EMA, and 3 (9.4%) expressed CEA, confirming the epithelial nature of this neoplasm. Reactivity for thyroglobulin was seen in a small number of cells in five (15.6%) thyroglobulin was seen in a small number of cells in five (15.6%) ATCs. Because all of the cases that expressed keratin also stained positively for EMA, CEA, or thyroglobulin, it is believed that keratin is the most useful epithelial marker for diagnosis of ATC. A lack of reactivity for calcitonin and Cg indicates that these tumors are not derived from C cells, as has been proposed by some authors. Reactivity for KP1 (CD68), a monoclonal antibody that reacts with a macrophage-associated antigen, occurred in the osteoclast-like cells but not in the anaplastic tumor cells. This finding, together with negative keratin staining of the osteoclast-like cells, indicates that these cells are not epithelial in nature and therefore should be considered reactive rather than neoplastic. Thirty tumors (93.8%) expressed vimentin, 15 (46.9%) marked for alpha 1AChy, 11 (34.4%) exhibited alpha 1AT, and 11 (34.4%) expressed S-100 protein. Because all of these markers can be seen in a wide variety of tumors of different histogeneses, they have no value in the diagnosis of ATC. Although immunostaining for FVIII:RAg, desmin, and MSA was negative in all of these tumors, these markers can help to differentiate between ATCs and some soft tissue sarcomas with which they can be confused.

Entities:  

Mesh:

Year:  1991        PMID: 1712540     DOI: 10.1093/ajcp/96.1.15

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

Review 1.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

2.  TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.

Authors:  Han-Ning Li; Ya-Ying Du; Tao Xu; Rui Zhang; Ge Wang; Zheng-Tao Lv; Xing-Rui Li
Journal:  Curr Med Sci       Date:  2021-01-11

Review 3.  Management of anaplastic thyroid cancer.

Authors:  Xavier M Keutgen; Samira M Sadowski; Electron Kebebew
Journal:  Gland Surg       Date:  2015-02

4.  Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases.

Authors:  Jeong Won Lee; Hye Sook Min; Sang Mi Lee; Hyun Woo Kwon; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2015-02-13

5.  Anaplastic carcinoma of the thyroid with rhabdomyosarcomatous differentiation: a report of two cases.

Authors:  Carmen Carda; Jaime Ferrer; Marien Vilanova; Amando Peydró; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2004-10-29       Impact factor: 4.064

6.  Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.

Authors:  Juliette Hommell-Fontaine; Angela Borda; Florence Ragage; Nicole Berger; Myriam Decaussin-Petrucci
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

7.  Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.

Authors:  Judit Pallares; Luis Perez-Ruiz; Susana Ros; Ma Jose Panades; Javier Pardo-Mindan; Josep Lloreta; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Peripheral Nerve Sheath Tumors of the Thyroid Gland: A Series of Four Cases and a Review of the Literature.

Authors:  Lester D. R. Thompson; Bruce M. Wenig; Carol F. Adair; Clara S. Heffess
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Elaine Spector; Andrea Behlmann; Kathryn Kronquist; Nancy C Rose; Elaine Lyon; Honey V Reddi
Journal:  Genet Med       Date:  2021-04-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.